1. Home
  2. WATT vs BIVI Comparison

WATT vs BIVI Comparison

Compare WATT & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energous Corporation

WATT

Energous Corporation

HOLD

Current Price

$5.97

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.59

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WATT
BIVI
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
14.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
WATT
BIVI
Price
$5.97
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
45.5K
65.1K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,018,000.00
N/A
Revenue This Year
$509.64
N/A
Revenue Next Year
$210.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
600.23
N/A
52 Week Low
$3.67
$1.25
52 Week High
$81.00
$30.00

Technical Indicators

Market Signals
Indicator
WATT
BIVI
Relative Strength Index (RSI) 39.72 52.45
Support Level $5.92 $1.45
Resistance Level $6.77 $1.70
Average True Range (ATR) 0.50 0.10
MACD 0.03 0.04
Stochastic Oscillator 14.18 75.56

Price Performance

Historical Comparison
WATT
BIVI

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: